Early cancer detection tools mostly involve circulating DNA (or cell-free DNA (cfDNA)) in the bloodstream. For instance, companies, such...

CB Insights’ Game Changers 2020 report features three biotech companies under the CRISPR 2.0 category. The report describes CRISPR 2.0 as...